Edition:
United States

H Lundbeck A/S (LUN.CO)

LUN.CO on Copenhagen Stock Exchange

291.90DKK
7:30am EST
Change (% chg)

kr.-1.00 (-0.34%)
Prev Close
kr.292.90
Open
kr.292.90
Day's High
kr.295.60
Day's Low
kr.289.90
Volume
103,266
Avg. Vol
465,722
52-wk High
kr.477.70
52-wk Low
kr.252.30

Chart for

About

H Lundbeck A/S is a Denmark-based company active in the pharmaceuticals industry. It is engaged in the research, development, manufacture and marketing of pharmaceuticals for the treatment of brain disorders, such as Alzheimer’s disease, Bipolar disorder, depression, epilepsy, Huntington’s disease, Parkinson’s disease and... (more)

Overall

Beta: 0.95
Market Cap(Mil.): kr.58,319.50
Shares Outstanding(Mil.): 199.11
Dividend: 12.00
Yield (%): 4.10

Financials

  LUN.CO Industry Sector
P/E (TTM): 14.90 32.78 36.27
EPS (TTM): 19.66 -- --
ROI: 27.22 13.04 12.64
ROE: 29.56 14.06 13.67

UPDATE 1-Danish drugmaker Lundbeck lowers dividend range to fuel growth

* Posts quarterly operating profit below analyst expectations (Adds detail, background, more quotes and share price)

Feb 05 2019

Drugmaker Lundbeck lowers dividend range to fuel growth

COPENHAGEN, Feb 4 Danish drugmaker Lundbeck said on Tuesday it will lower dividends to shareholders as it seeks to invest more to make up for declining sales of older drugs.

Feb 05 2019

UPDATE 1-Lundbeck shares slide as Danish drugmaker's new drugs disappoint

Nov 7 Shares in Lundbeck fell 5 percent on Wednesday after third-quarter sales of the Danish drugmaker's new drugs disappointed and it had to rely on its old line up to prop up revenues.

Nov 07 2018

Drug maker Lundbeck raises 2018 financial guidance

Nov 7 Danish drug maker Lundbeck raised its full-year financial guidance on Wednesday citing "better-than-expected sales performance".

Nov 07 2018

Earnings vs. Estimates